Molecular Switch Finding May Help Drive Stem Cells to Desired Cell Type
Using CRISPR, epigenetic researchers at the Babraham Institute in the United Kingdom control gene activity in human embryonic stem cells. The understanding of the targeted molecular switches on PRC2 increases the efficiency of differentiating stem cells, furthering their regenerative medicine research. Here are their findings: